Quantcast Alexion Pharmaceuticals Stock Quote | Stock Price for ALXN | Financial News | myMotherLode.com

Financial News

Motherlode Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alexion Pharmaceuticals (NQ: ALXN)
127.57 USD  +1.76 (+1.40%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jun 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,326,965
Open 125.71
Bid (Size) 118.54 (300)
Ask (Size) 127.75 (200)
Prev. Close 125.81
Today's Range 125.37 - 128.64
52wk Range 102.10 - 149.34
Shares Outstanding 222,500,663
Dividend Yield N/A
Performance
YTD
+2.84%
+2.84%
1 Month
+7.99%
+7.99%
3 Month
+15.15%
+15.15%
6 Month
+7.40%
+7.40%
1 Year
+1.06%
+1.06%
Top News
More News
Why This Biotech Company Could Shock 2019 Sales Expectations
Alexion surprised Wall Street on Tuesday when it asked the FDA for an expedited review of its newest rare-disease drug, ALXN1210. Read More
from Investor's Business Daily
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with PNH in the U.S. Read More
from Business Wire News Releases
More News
Read More
Alexion Announces Selection of Positive Phase 3 Clinical Data for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for Late-Breaking Oral Presentation at Annual Conference of the Eu
from Business Wire News Releases
Why Alexion's Blockbuster Franchise Is Safe From Copycats — For Now
from Investor's Business Daily
Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders
from Business Wire News Releases
Noteworthy Thursday Option Activity: LUV, AZO, ALXN
category Stocks
from Market News Video
Alexion to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
from Business Wire News Releases
Interesting ALXN Put And Call Options For February 2019
category Stocks
from Market News Video
Alexion Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for ALXN
category Stocks
from Market News Video
Analysts Anticipate IYH Will Reach $205
category ETFs
from ETF Channel
Alexion Offer for Wilson Therapeutics Accepted
from Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Follow myMotherLode.com at these social networks Make Us Your Homepage Today Follow us on Facebook Follow us on Twitter Follow us on Youtube Follow us on LinkedIn Follow our RSS Feed
Yellow Pages

Popular Searches

Local Radio Stations
© Copyright 2000-2017 Clarke Broadcasting Corporation. All rights reserved.